retatrutide mechanism triple agonist glp-1 gip glucagon receptor Demonstrated metabolic effects of GIP, and GCG agonism as mono, Semaglutide hits one receptor. Tirzepatide

The potential advent of an effective tau-directed disease-targeted therapies (DTTs) for AD may increase the volume of patients presenting earlier in the disease continuum, and increase complexity in workflow, infrastructure, treatment decision-making, treatment administration and monitoring, and patient tracking

Vitamin B12 significantly impacts the synthesis of energy and the development of red blood cells

Whereas ultrasound and FNA have been the two most commonly used imaging techniques for thyroid nodule assessment, each has some drawbacks (Sturgeon and Kim 2021)

Sinai Hospital, Toronto, Canada summarize and elucidate evidence that glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), initially developed for the treatment of type 2 diabetes and weight management, demonstrate a surprisingly broad range of clinical benefits